Infliximab for crohn disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 20 Oct 2004: Trial registered, NCT00094458
  2. 10 Dec 2008: Trial registered, NCT00805766

The trials

NCT00094458: Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC

State
Completed
Phase
Phase 3
People
508 taking part
Started
Mar 2005
Primary completion
Apr 2008
Arms
002
Results
Posted on the registry
  1. 20 Oct 2004: Trial registered
  2. 23 Jun 2009: Trial results posted

NCT00805766: Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

State
Completed
Phase
Phase 3
People
39 taking part
Started
Dec 2008
Primary completion
Nov 2009
Arms
TA-650
Results
Posted on the registry
  1. 10 Dec 2008: Trial registered
  2. 5 Dec 2012: Trial results posted

How the status changed

  1. 16 Nov 2026: First set: Trial registered

About the treatment

Also known as infliximab infusion; AZA placebo caps.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.